Calculated based on number of publications stored in Pure and citations from Scopus
1982 …2024

Research activity per year

Filter
Chapter

Search results

  • Bile acid sequestrants: Risk– benefits and role in treating dyslipidemias

    Ganda, O. P. & Garg, A., Jan 1 2015, Dyslipidemias: Pathophysiology, Evaluation and Management. Humana Press Inc., p. 453-463 11 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

    1 Scopus citations
  • Familial Partial Lipodystrophy Presenting as Extreme Hypertriglyceridemia and Acute Pancreatitis

    Garg, A., Jan 1 2022, A Case-Based Guide to Clinical Endocrinology, Third Edition. Springer International Publishing, p. 413-419 7 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

  • Genetic Lipodystrophies

    Garg, A., Jan 1 2020, Emery and Rimoin’s Principles and Practice of Medical Genetics and Genomics: Metabolic Disorders. Elsevier, p. 25-48 24 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

  • Genetic Lipodystrophies

    Garg, A., Jan 1 2013, Emery and Rimoin's Principles and Practice of Medical Genetics. Elsevier, p. 1-16 16 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

    2 Scopus citations
  • Lipodystrophies

    Garg, A., Oct 23 2015, Genetic Diagnosis of Endocrine Disorders: Second Edition. Elsevier Inc., p. 325-339 15 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

    3 Scopus citations
  • Lipodystrophies and dyslipidemias

    Garg, A., Jan 1 2015, Dyslipidemias: Pathophysiology, Evaluation and Management. Humana Press Inc., p. 287-302 16 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

    2 Scopus citations
  • Novel lipid-lowering agents

    Ahmad, Z. & Garg, A., Jan 1 2015, Dyslipidemias: Pathophysiology, Evaluation and Management. Humana Press Inc., p. 499-519 21 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter